Transcription of EASL Clinical Practice Guidelines: Autoimmune hepatitisq
{{id}} {{{paragraph}}}
EASL Clinical Practice Guidelines: Autoimmune hepatitisqEuropean Association for the Study of the Liver IntroductionAutoimmune hepatitis (AIH) was the first liver disease for whichan effective therapeutic intervention, corticosteroid treatment,was convincingly demonstrated in controlled Clinical , 50 years later AIH still remains a major diagnosticand therapeutic challenge. There are two major reasons for thisapparent contradiction: Firstly, AIH is a relatively rare , AIH is a very heterogeneous other rare diseases, Clinical studies are hampered by thelimited number of patients that can be included in trials. Possiblyand more importantly, the interest of the pharmaceutical indus-try to develop effective specific therapies for rare diseases is lim-ited due to the very restricted market for such products.
AIH prevalence and clinical expression seem to vary according to ethnicity. Alaskan natives appear to have a high frequency of acute icteric disease at the disease onset [12], and the disease is more common and more severe in North American Aboriginal/First Nations populations compared with predomi-nantly Caucasian, non-First Nations ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Clinical, American College of Gastroenterology, American, ACG clinical, Of Gastroenterology, ACG Clinical Guideline: Diagnosis and Management of, College, College of Gastroenterology, American Gastroenterology, American Col-lege of Gastroenterology, Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage